SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-311617
Filing Date
2022-12-23
Accepted
2022-12-23 09:59:06
Documents
17
Period of Report
2022-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d432569d8k.htm   iXBRL 8-K 29609
2 EX-99.1 d432569dex991.htm EX-99.1 20686
7 GRAPHIC g432569g02v89.jpg GRAPHIC 20391
8 GRAPHIC g432569g38b35.jpg GRAPHIC 10276
9 GRAPHIC g432569g55h37.jpg GRAPHIC 6149
  Complete submission text file 0001193125-22-311617.txt   269506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20221223.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20221223_def.xml EX-101.DEF 13822
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20221223_lab.xml EX-101.LAB 22923
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20221223_pre.xml EX-101.PRE 14702
11 EXTRACTED XBRL INSTANCE DOCUMENT d432569d8k_htm.xml XML 5681
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 221483685
SIC: 2836 Biological Products, (No Diagnostic Substances)